Corelogic (CLGX)

80  +0.47 (+0.59%)

After market: 79.98 -0.02 (-0.02%)

Fundamental Rating

1

Overall CLGX gets a fundamental rating of 1 out of 10. We evaluated CLGX against 81 industry peers in the Professional Services industry. Both the profitability and financial health of CLGX have multiple concerns. CLGX is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year CLGX was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 7.42%
ROE 42.47%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 21.1%
PM (TTM) 18.75%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

There is no outstanding debt for CLGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CLGX has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.84% over the past year.
Measured over the past years, CLGX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.82% on average per year.
Looking at the last year, CLGX shows a decrease in Revenue. The Revenue has decreased by -4.26% in the last year.
CLGX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.45% yearly.
EPS 1Y (TTM)55.84%
EPS 3Y24%
EPS 5Y18.82%
EPS growth Q2Q57.89%
Revenue 1Y (TTM)-4.26%
Revenue growth 3Y-3.91%
Revenue growth 5Y1.45%
Revenue growth Q2Q-4.75%

3.2 Future

Based on estimates for the next years, CLGX will show a small growth in Earnings Per Share. The EPS will grow by 0.99% on average per year.
CLGX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.66% yearly.
EPS Next Y-3.64%
EPS Next 2Y-2.44%
EPS Next 3Y0.51%
EPS Next 5Y0.99%
Revenue Next Year4.62%
Revenue Next 2Y1.56%
Revenue Next 3Y1.56%
Revenue Next 5Y0.66%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.19, CLGX is valued correctly.
CLGX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.28.
The Price/Forward Earnings ratio is 18.68, which indicates a rather expensive current valuation of CLGX.
CLGX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.19
Fwd PE 18.68

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.51

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.86
EPS Next 2Y-2.44%
EPS Next 3Y0.51%

2

5. Dividend

5.1 Amount

CLGX has a Yearly Dividend Yield of 1.65%.
Compared to the average S&P500 Dividend Yield of 2.41, CLGX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.65%

5.2 History

CLGX does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

CLGX pays out 28.80% of its income as dividend. This is a sustainable payout ratio.
DP28.8%
EPS Next 2Y-2.44%
EPS Next 3Y0.51%

Corelogic

NYSE:CLGX (6/3/2021, 7:12:16 PM)

After market: 79.98 -0.02 (-0.02%)

80

+0.47 (+0.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.89B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.65%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.19
Fwd PE 18.68
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.86
Profitability
Industry RankSector Rank
ROA 7.42%
ROE 42.47%
ROCE
ROIC
ROICexc
ROICexgc
OM 21.1%
PM (TTM) 18.75%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)55.84%
EPS 3Y24%
EPS 5Y
EPS growth Q2Q
EPS Next Y-3.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.26%
Revenue growth 3Y-3.91%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y